Bridgewater Associates’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,461
Closed -$669K 916
2024
Q1
$669K Sell
17,461
-2,449
-12% -$119K ﹤0.01% 600
2023
Q4
$1.34M Sell
19,910
-2,016
-9% -$140K 0.01% 594
2023
Q3
$1.64M Buy
21,926
+1,017
+5% +$90.2K 0.01% 527
2023
Q2
$1.93M Sell
20,909
-1,271
-6% -$113K 0.01% 464
2023
Q1
$2.3M Sell
22,180
-648
-3% -$71.8K 0.01% 436
2022
Q4
$2.63M Sell
22,828
-7,577
-25% -$882K 0.01% 486
2022
Q3
$3.29M Sell
30,405
-13,714
-31% -$1.97M 0.02% 464
2022
Q2
$7.96M Buy
44,119
+13,688
+45% +$2.45M 0.03% 381
2022
Q1
$5.2M Buy
30,431
+7,011
+30% +$1.32M 0.02% 459
2021
Q4
$4.91M Buy
23,420
+3,044
+15% +$629K 0.03% 300
2021
Q3
$3.92M Sell
20,376
-594
-3% -$146K 0.02% 326
2021
Q2
$5.93M Buy
+20,970
New +$5.68M 0.04% 302

Other funds holding MED